Glycoproteomic Discovery of Serological Biomarker Candidates for HCV/HBV Infection-Associated Liver Fibrosis and Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Glycoproteomic Discovery of Serological Biomarker Candidates for HCV/HBV Infection-Associated Liver Fibrosis and Hepatocellular Carcinoma

Published:2013-04-30 Issue:6 Volume:12 Page:2630-2640
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Kaji Hiroyuki¹,Ocho Makoto¹,Togayachi Akira¹,Kuno Atsushi¹,Sogabe Maki¹,Ohkura Takashi¹,Nozaki Hirofumi¹,Angata Takashi¹,Chiba Yasunori¹,Ozaki Hidenori¹,Hirabayashi Jun¹,Tanaka Yasuhito²,Mizokami Masashi²,Ikehara Yuzuru¹,Narimatsu Hisashi¹

Affiliation:

1. Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki, Japan

2. Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Mizuho, Nagoya, Aichi, Japan

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr301217b

Reference50 articles.

1. Epidemiology of hepatocellular carcinoma in Japan

2. Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan